Showing results (2471-2480 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|September 10, 2021
Pathogenic DPYD Variants and Treatment-Related Mortality in Patients Receiving Fluoropyrimidine Chemotherapy: A Systematic Review and Meta-AnalysisBhavina B Sharma, Karan Rai, Heather Blunt, et al.
The Oncologist|September 10, 2021
Treatment Patterns and Outcomes of Women with Symptomatic and Asymptomatic Breast Cancer Brain Metastases: A Single-Center Retrospective StudyYizhuo Kelly Gao, Markus Kuksis, Badr Id Said, et al.
The Oncologist|May 24, 2021
Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA TrialSara A Hurvitz, Cristina Saura, Mafalda Oliveira, et al.
The Oncologist|August 3, 2021
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective ReviewDavid L Chan, Emily K Bergsland, Jennifer A Chan, et al.
The Oncologist|August 3, 2021
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint InhibitorsDylan J Martini, Julie M Shabto, Subir Goyal, et al.
The Oncologist|September 12, 2021
Changes in Cancer Patients' and Caregivers' Disease Perceptions While Receiving Early Palliative Care: A Qualitative and Quantitative AnalysisEleonora Borelli, Sarah Bigi, Leonardo Potenza, et al.
The Oncologist|September 13, 2021
Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Patients with Cancer Receiving PD-1/PD-L1 Blockade TherapiesZhaoli Tan, Chunyan Yue, Shoujian Ji, et al.
The Oncologist|May 15, 2020
Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical RelevanceShen Zhao, Ding Ma, Yi Xiao, et al.
The Oncologist|January 31, 2023
Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian CancerRichard T Penson, Allison J Ambrosio, Christin A Whalen, et al.
The Oncologist|February 13, 2023
Feasibility of a Geriatric Oncology Longitudinal End to End (GOLDEN) Program in a Tertiary Cancer Center in SingaporeFrancis Ho, Alfred Kow, Wan Chin Lim, et al.
Pageof 571